ARCHIVES

NCI Study Says 2 Million US Women Could Benefit from Tamoxifen

This article is from The Cancer Letter archive.

Vol. 29 No. 15 | April 11, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Fox Chase Joins Temple Health System, Expands Outpatient and Surgical Services

July 6, 2012

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

Avastin Loses Indication for Breast Cancer

November 18, 2011

Obituary: Selma Schimmel, Founder of Vital Options, Dies of Cancer

May 23, 2014

$5 Million Lift Raises Payline From 180 to 185

May 21, 1982

In Brief: Breast Cancer Stamp Unveiled; Payne Moves To MSK; Survivor To Bike Across U.S.

July 31, 1998